Nontypeable Haemophilus influenzae P5 Binds Human C4b-Binding Protein, Promoting Serum Resistance

Oskar Thofte1, Serena Bettoni2, Yu-Ching Su1

  • 1Clinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Malmö, Sweden.

Insights

Nontypeable Haemophilus influenzae (NTHi) uses outer membrane protein 5 (P5) to bind complement-binding protein (C4BP), enhancing its survival. P5 expression is higher in severe respiratory infections, aiding NTHi immune evasion.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogen-host interactions

Background:

  • Nontypeable Haemophilus influenzae (NTHi) is a significant human pathogen causing respiratory infections.
  • NTHi evades the complement system, a crucial part of innate immunity, for survival.
  • Complement-binding protein (C4BP) binding is known to be important for NTHi complement evasion.

Purpose of the Study:

  • To identify novel NTHi surface proteins involved in complement evasion.
  • To investigate the role of outer membrane protein 5 (P5) in NTHi's interaction with C4BP.
  • To correlate P5 expression with C4BP binding and serum resistance in clinical isolates.

Main Methods:

  • Identification of NTHi outer membrane protein 5 (P5) as a C4BP ligand.
  • Construction and analysis of P5-deficient NTHi mutants.
  • Surface expression of recombinant P5 on Escherichia coli.
  • Correlation analysis of P5 expression and C4BP binding in clinical NTHi isolates.

Main Results:

  • NTHi outer membrane protein 5 (P5) was identified as a novel ligand for C4BP.
  • P5-deficient NTHi mutants showed reduced C4BP binding and decreased serum resistance.
  • Recombinant P5 expression on E. coli conferred C4BP binding and enhanced serum resistance.
  • P5 surface expression and C4BP binding levels were higher in isolates from lower respiratory tract infections and tonsils.

Conclusions:

  • Outer membrane protein 5 (P5) is a key factor for NTHi complement evasion.
  • P5 facilitates NTHi survival by promoting C4BP binding, thereby conferring resistance to complement-mediated killing.
  • P5 expression levels correlate with infection site, suggesting its importance in specific NTHi pathogenesis.

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...